Assessment of prognosis in alcoholic liver disease: Can serum hyaluronate replace liver biopsy?

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 9, 2003, Pages 941-944

  Phillips, Martin G ^a,b   Preedy, Victor R ^c   Hughes, Robin D ^d  

^a Department of Gastroenterology ^*  (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alcoholic liver disease; Hyaluronic acid; Prognosis

Indexed keywords

HYALURONIC ACID;

ACCURACY; ALCOHOL LIVER DISEASE; BIOLOGICAL MONITORING; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; LIVER BIOPSY; LIVER INJURY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW;

BIOLOGICAL MARKERS; BIOPSY; HUMANS; HYALURONIC ACID; LIVER; LIVER DISEASES, ALCOHOLIC; PROGNOSIS;

EID: 0041760773     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200309000-00001     Document Type: Review

References (29)

1. Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 1981; 282:263-266.
2. Lelbach WK. Liver damage in chronic alcoholism. Results of a clinical, clinical-chemical and bioptic-histologic study of 526 alcoholic patients during withdrawal treatment in a public hospital for alcoholics. Acta Hepatosplenol 1967; 14:9-39.
3. Hardison W, Lee F. Prognosis in acute liver disease of the alcoholic patient. N Engl J Med 1966; 275:61-66.
4. Schenker S. Medical consequences of alcohol abuse: is gender a factor? Alcohol Clin Exp Res 1997; 21:179-181.
5. Enomoto N, Takase S, Takada N, Takada A. Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes. Hepatology 1991; 13:1071-1075.
6. Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991; 12:162-169.
7. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulatin9 tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatotogy 1991; 13:267-276.
8. Sun AY, Ingelman-Sundberg M, Neve E, Matsumoto H, Nishitani Y, Minowa Y, et al. Ethanol and oxidative stress. Alcohol Clin Exp Res 2001; 25:237S-243S.
9. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997; 26:143-146.
10. Tsukamoto H. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol 1993; 10:465-467.
11. Nanji AA, Tahan SR, Khwaja S, Yacoub LK, Sadrzadeh SM. Elevated plasma levels of hyaluronic acid indicate endothelial cell dysfunction in the initial stages of alcoholic liver disease in the rat. J Hepatol 1996; 24:368-374.
12. Ferro D, Quintatelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, Violi F. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxaemia. Hepatology 1996; 23:1377-1383.
13. Albornoz L, Alvarez D, Otaso JC, Gadano A, Salviu J, Gerona S, et al. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels. J Hepatol 1999; 30:451-455.
14. McCullough A J, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998; 93:2022-2036.
15. Lindqvist U. Is serum hyaluronan a helpful tool in the management of patients with liver diseases? J Intern Med 1997; 242:67-71.
16. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedosa P, Aube C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113:1609-1616.
17. Plevris JN, Haydon GH, Simpson KJ, Dawkes R, Ludlam CA, Harrison DJ, Hayes PC. Serum hyaluronan - a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol 2000; 12:1121-1127.
18. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, et al. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology 1993; 105:475-481.
19. Urashima S, Tsutsumi M, Nakase K, Takase S, Takada S. Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol 1993; 28:77-84.
20. Urashima S, Tsutsumi M, Shimanaka K, Ueshima Y, Tsuchishima M, Itoh T, et al. Histochemical study of hyaluronate in alchoholic liver disease. Alcoholism Clin Exp Res 1999; 23:56S-60S.
21. Pares A, Deulofeu R, Giminez A, Caballeria L, Bruguera M, Caballeria J, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24:1399-1403.
22. Frebourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, Bourreille J. Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 1986; 6:392-395.
23. Plebani M, Giacomini A, Floreani A, Chiaramonte M, Soffiati G, Naccarato R, Burlina A. Biochemical markers of hepatic fibrosis in primary biliary cirrhosis. Res Clin Lab 1990; 20:269-274.
24. Wong VS, Hughes V, Trull A, Wright DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepatol 1998; 5:187-192.
25. Stickel F, Poeschl G, Schuppan D, Conradt C, Strenge-Hesse A, Fuchs FS, et al. Serum hyaluronate correlates with histological progression in alcoholic liver disease. Eur J Gastroenterol Hepatol 2003; 15:945-950.
26. Tsutsumi M, Urashima S, Matsuda Y, Takase S, Takada A. Changes in type IV collagen content in livers of patients with alcoholic liver disease. Hepatology 1993; 17:820-827.
27. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 78:193-199.
28. Williams AM, Langley PG, Osei-Hwediah J, Wendon JA, Hughes RD. Hyaluronic acid and endothelial damage in paracetamol-induced hepatotoxicity. Liver Int 2003; 23:110-115.
29. Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, et al. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol 2000; 24:626-630.